The effectiveness of psychological interventions alone, or in combination with phosphodiesterase-5 inhibitors, for the treatment of erectile dysfunction:A systematic review

被引:6
|
作者
Atallah, Sandrine [1 ]
Haydar, Asad [2 ]
Jabbour, Teddy [2 ]
Kfoury, Peter [3 ]
Sader, Georgio [2 ]
机构
[1] Amer Univ Beirut Med Ctr AUBMC, Dept Obstet & Gynecol, Beirut, Lebanon
[2] Univ Balamand, Fac Med, Koura, Lebanon
[3] Amer Univ Beirut, Fac Med, Beirut, Lebanon
关键词
Erectile dysfunction; systematic review; psychological intervention; combined therapy; phosphodiesterase; 5; inhibitors; cognitive behavioural therapy; 4TH INTERNATIONAL CONSULTATION; COGNITIVE-BEHAVIORAL THERAPY; SEX THERAPY; CONSENSUS STATEMENT; ADJUNCT TREATMENT; YOUNG MEN; HEALTH; SILDENAFIL; MEDICINE; PSYCHOTHERAPY;
D O I
10.1080/2090598X.2021.1926763
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To highlight the efficacy of various psychological interventions (PI) when used in combination with, or in place of, phosphodiesterase-5 inhibitors (PDE-5i), as compared to the traditional treatment of men with erectile dysfunction (ED) with PDE-5i alone. Methods: A comprehensive literature review for the years 2005-2020 via MEDLINE and PubMed. We included randomised controlled trials that compared the use of either PDE-5i alone, PI alone or a combination of PDE-5i and PI in the treatment of psychogenic ED. All studies included were performed in adults aged 19-55 years and were written in English. Results: A total of 13 articles, with an overall sample of 597 men, were included in this systematic review. The results show that the combination of PI and PDE-5i was more effective than either PI or PDE-5i alone, on erectile function and long-term sexual satisfaction in men with psychogenic ED. Combined interventions were found to be significantly superior to medical treatment in seven studies and to PI alone in one study. In comparing PI to PDE-5i, two studies found PI to be significantly superior to PDE-51 use. In three other studies, PI was found significantly superior to no treatment at all, although some participants in the control group had taken PDE-5i. Conclusions: The combination of PDE-5i with PI shows real promise for the treatment of psychogenic ED. However, no conclusions could be made about what PI is more promising than the other and larger studies are needed to confirm these initial findings.
引用
收藏
页码:310 / 322
页数:13
相关论文
共 50 条
  • [42] Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction
    Dorsey, Philip
    Keel, Christopher
    Klavens, Meghan
    Hellstrom, Wayne J. G.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1109 - 1122
  • [43] New phosphodiesterase inhibitors in the treatment of erectile dysfunction
    Anderson, PCB
    Gommersall, L
    Hayne, D
    Arya, M
    Patel, HRH
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) : 2241 - 2249
  • [44] Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction
    Yafi, Faysal A.
    Sharlip, Ira D.
    Becher, Edgardo F.
    [J]. SEXUAL MEDICINE REVIEWS, 2018, 6 (02) : 242 - 252
  • [45] Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan
    Jiann, Bang-Ping
    [J]. UROLOGICAL SCIENCE, 2016, 27 (02) : 66 - 70
  • [46] An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors
    Bruzziches, Roberto
    Francomano, Davide
    Gareri, Pietro
    Lenzi, Andrea
    Aversa, Antonio
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (10) : 1333 - 1344
  • [47] Sexually transmitted infection in HIV-positive men with erectile dysfunction using phosphodiesterase-5 inhibitors
    McCarty, E. J.
    Quinn, K.
    Dinsmore, W. W.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 (06) : 455 - 455
  • [48] Combination of phosphodiesterase-5 inhibitors and α-blockers in patients with benign prostatic hyperplasia:: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Carson, CC
    [J]. BJU INTERNATIONAL, 2006, 97 : 39 - 43
  • [49] Causes of ineffectiveness of phosphodiesterase-5 inhibitors in patients with diabetes mellitus and erectile dysfunction (rational therapy tactics)
    Kalinchenko, S. Y.
    Rozhivanov, R., V
    [J]. DIABETES MELLITUS, 2006, 9 (01): : 54 - 57
  • [50] Avanafil, a Potent and Highly Selective Phosphodiesterase-5 Inhibitor for Erectile Dysfunction
    Kotera, Jun
    Mochida, Hideki
    Inoue, Hirotaka
    Noto, Tsunehisa
    Fujishige, Kotomi
    Sasaki, Takashi
    Kobayashi, Tamaki
    Kojima, Koki
    Yee, Shiyin
    Yamada, Yasuhiro
    Kikkawa, Kohei
    Omori, Kenji
    [J]. JOURNAL OF UROLOGY, 2012, 188 (02): : 668 - 674